- Home
- CRIS vs SOND Comparison
CRIS vs SOND Comparison
Compare CRIS & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- SOND
- Stock Information
- Founded
- CRIS 2000
- SOND 2014
- Country
- CRIS United States
- SOND United States
- Employees
- CRIS N/A
- SOND N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- SOND Hotels/Resorts
- Sector
- CRIS Health Care
- SOND Consumer Discretionary
- Exchange
- CRIS Nasdaq
- SOND Nasdaq
- Market Cap
- CRIS 21.3M
- SOND 23.2M
- IPO Year
- CRIS 2000
- SOND N/A
- Fundamental
- Price
- CRIS $2.37
- SOND $1.83
- Analyst Decision
- CRIS Strong Buy
- SOND
- Analyst Count
- CRIS 2
- SOND 0
- Target Price
- CRIS $16.50
- SOND N/A
- AVG Volume (30 Days)
- CRIS 76.2K
- SOND 43.5K
- Earning Date
- CRIS 07-31-2025
- SOND 06-17-2025
- Dividend Yield
- CRIS N/A
- SOND N/A
- EPS Growth
- CRIS N/A
- SOND N/A
- EPS
- CRIS N/A
- SOND N/A
- Revenue
- CRIS $11,202,000.00
- SOND $624,458,000.00
- Revenue This Year
- CRIS $0.93
- SOND $28.50
- Revenue Next Year
- CRIS $8.10
- SOND $17.62
- P/E Ratio
- CRIS N/A
- SOND N/A
- Revenue Growth
- CRIS 14.17
- SOND 8.32
- 52 Week Low
- CRIS $1.02
- SOND $0.88
- 52 Week High
- CRIS $9.72
- SOND $10.50
- Technical
- Relative Strength Index (RSI)
- CRIS 59.94
- SOND 36.71
- Support Level
- CRIS $2.23
- SOND $1.77
- Resistance Level
- CRIS $2.63
- SOND $1.86
- Average True Range (ATR)
- CRIS 0.18
- SOND 0.11
- MACD
- CRIS 0.03
- SOND -0.00
- Stochastic Oscillator
- CRIS 67.09
- SOND 22.22
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.